Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA

World Journal of Gastroenterology

Volumn 11, Issue 1, 2005, Pages 46-50

  Wang, Yong Zhong ^a   Cao, You Qing ^a   Wu, Jian Nong ^a   Chen, Miao ^a   Cha, Xiao Ying ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Gastric carcinoma; Nitric oxide synthases; P53 protein; PCNA

Indexed keywords

CYCLINE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA;

EID: 11844301247     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i1.46     Document Type: Article

References (30)

1. Janssens MY, Van den Berge DL, Verovski VN, Monsaert C, Storme GA. Activation of inducible nitric oxide synthase results in nitric oxide-mediated radiosensitization of hypoxic EMT-6 tumor cells. Cancer Res 1998; 58: 5646-5648
2. Goto T, Haruma K, Kitadai Y, Ito M, Yoshihara M, Sumii K, Hayakawa N, Kajiyama G. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin Cancer Res 1999; 5: 1411-1415
3. Wink DA, Vodovotz Y, Cook JA, Krishna MC, Kim S, Coffin D, DeGraff W, Deluca AM, Liebmann J, Mitchell JB. The role of nitric oxide chemistry in cancer treatment. Biochemistry 1998; 63: 802-809
4. Hamaoka R, Yaginuma Y, Takahashi T, Fujii J, Koizumi M, Seo HG, Hatanaka Y, Hashizume K, Ii K, Miyagawa J, Hanafusa T, Matsuzawa Y, Ishikawa M, Taniguchi N. Different expression patterns of nitric oxide synthase isozymes in various gynecological cancers. J Cancer Res Clin Oncol 1999; 125: 321-326
5. Wolf H, Haeckel C, Roessner A. Inducible nitric oxide synthase expression in human urinary bladder cancer. Virchows Arch 2000; 437: 662-666
6. Oyoshi T, Nomoto M, Hirano H, Kuratsu J. Pathodynamics of nitric oxide production within implanted glioma studied with an in vivo microdialysis technique and immunohistochemistry. J Pharmacol Sci 2003; 91: 15-22
7. Hallinan EA, Tsymbalov S, Dorn CR, Pitzele BS, Hansen DW Jr, Moore WM, Jerome GM, Connor JR, Branson LF, Widomski DL, Zhang Y, Currie MG, Manning PT. Synthesis and biological characterization of L-N (6)-(1-iminoethyl) lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor. J Med Chem 2002; 45: 1686-1689
8. Doi C, Noguchi Y, Marat D, Saito A, Fukuzawa K, Yoshikawa T, Tsuburaya A, Ito T. Expression of nitric oxide synthase in gastric cancer. Cancer Lett 1999; 144: 161-167
9. Kojima M, Morisaki T, Tsukahara Y, Uchiyama A, Matsunari Y, Mibu R, Tanaka M. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J Surg Oncol 1999; 70: 222-229
10. Thomsen LL, Miles DW. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 1998; 17: 107-118
11. Rajnakova A, Goh PM, Chan ST, Ngoi SS, Alponat A, Moochhala S. Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue. Carcinogenesis 1997; 18: 1841-1845
12. Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998; 58: 334-341
13. Rajnakova A, Moochhala S, Goh PM, Ngoi S. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett 2001; 172: 177-185
14. Kim SS, Bhang CS, Min KO, Chae HS, Choi SW, Lee CD, Lim KW, Chung IS, Park DH. p53 mutations and microsatellite instabilities in the subtype of intestinal metaplasia of the stomach. J Korean Med Sci 2002; 17: 490-496
15. Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. Jpn J Clin Oncol 2003; 33: 173-179
16. Tao K, Chen D, Tian Y, Lu X, Yang X. The relationship between apoptosis and the expression of proliferating cell nuclear antigen and the clinical stages in gastric carcinoma. J Tongji Med Univ 2000; 20: 222-224
17. Fujimoto H, Ando Y, Yamashita T, Terazzki H, Tanaka Y, Sasaki J, Matsumoto M, Suga M, Ando M. Nitric oxide synthase activity in human lung cancer. Jpn J Cancer Res 1997; 88: 1190-1198
18. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995; 72: 41-44
19. Koh E, Noh SH, Lee YD, Lee HY, Han JW, Lee HW, Hong S. Differential expression of nitric oxide synthase in human stomach cancer. Cancer Lett 1999; 146: 173-180
20. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG. The role of nitric oxide in cancer. Cell Res 2002; 12: 311-320
21. Peng JP, Zheng S, Xiao ZX, Zhang SZ. Inducible nitric oxide synthase expression is related to angiogenesis, bcl-2 and cell proliferation in hepatocellular carcinoma. J Zhejiang Univ Sci 2003; 4: 221-227
22. Gallo O, Schiavone N, Papucci L, Sardi I, Magnelli L, Franchi A, Masini E, Capaccioli S. Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma. Am J Pathol 2003; 163: 723-732
23. Cinel L, Polat A, Aydin O, Dusmez D, Egilmez R. Bcl-2, iNOS, p53 and PCNA expression in normal, disordered proliferative, hyperplastic and malignant endometrium. Pathol Int 2002; 52: 384-389
24. Pukkila MJ, Kellokoski JK, Virtaniemi JA, Kumpulainen EJ, Johansson RT, Halonen PM, Kosunen AS, Nuutinen J, Kosma VM. Inducible nitric oxide synthase expression in pharyngeal squamous cell carcinoma: relation to p53 expression, clinicopathological data, and survival. Laryngoscope 2002; 112: 1084-1088
25. Matsumoto M, Furihata M, Kurabayashi A, Araki K, Sasaguri S, Ohtsuki Y. Association between inducible nitric oxide synthase expression and p53 status in human esophageal squamous cell carcinoma. Oncology 2003; 64: 90-96
26. Feng CW, Wang LD, Jiao LH, Liu B, Zheng S, Xie XJ. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2002; 2: 8
27. Kato S, Esumi H, Hirano A, Kato M, Asayama K, Ohama E. Immunohistochemical expression of inducible nitric oxide synthase (iNOS) in human brain tumors: relationships of iNOS to superoxide dismutase (SOD) proteins (SOD1 and SOD2), Ki67 antigen (MIB-1) and p53 protein. Acta Neuropathol 2003; 105: 333-340
28. Ohshima H, Tatemichi M, Sawa T. Chemical basis of inflammation-induced carcinogenesis. Arch Biochem Biophys 2003; 417: 3-11
29. Rajnakova A, Moochhala S, Goh PM, Ngoi S. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett 2001; 172: 177-185
30. Aaltoma SH, Lipponen PK, Kosma VM. Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Anticancer Res 2001; 21: 3101-3106